Free delivery nationwide for orders above ₱800

RXDRUG-DR-XY21335

HEPA-MERZ L-Ornithine-L-Aspartate 3g Granules for Oral Solution 5g 10's

Contact us for a price
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications/Uses

Acute and chronic liver disease eg, liver cirrhosis, fatty liver, hepatitis, associated with hyperammonemia; especially for the treatment of neurological complications (hepatic encephalopathy).
 

Dosage/Direction for Use

Granules: Unless prescribed otherwise, take 1-2 sachets of Hepa-Merz up to 3 times daily. Dissolve the contents of the sachet in plenty of liquid (eg, glass of water, tea or juice), and drink after meals. If required, the dosage may be increased without risk.
Infusion: Usually up to 4 ampule daily.
Associated with Incipient disturbance of consciousness (pre-coma): Up to 8 ampule/24 hr, depending on the severity of the condition. Maximum Infusion Rate: 5 g/hr.
Associated with venous tolerance: Should not exceed 6 ampule/500 mL infusion.
 

Administration

Should be taken with food: Granules: Take immediately after meals. Dissolve in a glass of water, tea or juice.
 

Contraindications

Severe renal dysfunction (renal insufficiency). A serum creatinine level exceeding 3 mg/100 mL can be regarded as a reference value.
 

Adverse Reactions

Transient GI complaints, nausea, vomiting.
 

Storage

Store at temperatures not exceeding 30°C.
 

Action

L-ornithine-L-aspartate stimulates ammonia detoxification by enhancing urea synthesis in the urea cycle. Additionally, it eliminates extrahepatic ammonia from the tissues.
 

MedsGo Class

Cholagogues, Cholelitholytics & Hepatic Protectors

Features

Dosage
3 g
Ingredients
  • L-Ornithine-L-Aspartate
Packaging
Granule for Solution 5g x 10's
Generic Name
L-Ornithine-L-Aspartate
Registration Number
DR-XY21335
Classification
Prescription Drug (RX)
Find similar

Product Questions

Questions